Spread of a multiresistant CTX-M-9-producing Salmonella enterica serotype Virchow phage type 19 in Spain.
The purpose of this study was to survey Salmonella enterica serotype Virchow phage type 19 (S. Virchow PT19) strains submitted to the Spanish National Reference Laboratory for Salmonella (SNRLS) from 2002 to 2006 in order to determine the rate type and genetic background of beta-lactam resistance and to further identify the associated resistances. Ninety-nine S. Virchow PT19 strains were analysed. Antimicrobial susceptibility was determined by the disk diffusion method using Mueller-Hinton agar medium. Polymerase chain reaction (PCR) assays and, later, sequencing of the obtained fragments were performed for the molecular characterisation of the resistances. Pulsed-field gel electrophoresis (PFGE) and plasmid analysis (using conjugation, Southern blot hybridisation and replicon typing) were used for characterisation. The characterisation of S. Virchow PT19 strains allowed the identification of a clonal multiresistant S. Virchow PT19 harbouring an IncH12 plasmid with the bla (CTX-M-9) gene within the complex integron In60 distributed across Spain. An IncH12 plasmid widely reported and studied in Enterobacteria is described in a clonal multiresistant S. Virchow PT19 which has successfully spread throughout Spain.
Herrera-León
S
S
Servicio de Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2, 28220 Majadahonda, Madrid, Spain. sherrera@isciii.es
González-Sanz
R
R
Rodríguez
I
I
Rodicio
M R
MR
Echeita
M A
MA
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000096:biosynthesis* / Q000235:genetics; D001434:Bacteriophage Typing; D016000:Cluster Analysis; D016172:DNA Fingerprinting; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D016521:Electrophoresis, Gel, Pulsed-Field; D029968:Escherichia coli Proteins / Q000096:biosynthesis* / Q000235:genetics; D005838:Genotype; D006801:Humans; D032023:Integrons; D008826:Microbial Sensitivity Tests; D010957:Plasmids / Q000032:analysis; D016133:Polymerase Chain Reaction; D012480:Salmonella Infections / Q000453:epidemiology* / Q000382:microbiology; D019779:Salmonella enterica / Q000145:classification* / Q000201:enzymology / Q000302:isolation & purification*; D017422:Sequence Analysis, DNA; D013030:Spain / Q000453:epidemiology; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics; D047090:beta-Lactams / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D029968:Escherichia coli Proteins; D047090:beta-Lactams; C412613:CTX-M-9 protein, E coli; D001618:beta-Lactamases
J Microbiol Methods. 2005 Dec;63(3):219-28
15935499
Int J Antimicrob Agents. 2008 Aug;32(2):158-64
18571383
Microb Drug Resist. 2002 Winter;8(4):281-9
12523625
Antimicrob Agents Chemother. 2002 Aug;46(8):2656-61
12121950
J Clin Microbiol. 2006 Aug;44(8):2897-903
16891509
J Clin Microbiol. 2004 Dec;42(12):5767-73
15583311
Nat Rev Microbiol. 2006 Aug;4(8):608-20
16845431
FEMS Microbiol Lett. 2007 Jun;271(1):71-7
17391369
Clin Microbiol Infect. 2006 Oct;12(10):999-1005
16961637
Clin Microbiol Infect. 2009 Mar;15(3):292-5
19175621